LifeStance Health Group (NASDAQ:LFST – Free Report) had its price target reduced by JPMorgan Chase & Co. from $10.00 to $8.00 in a report published on Friday, Benzinga reports. They currently have a neutral rating on the stock.
LifeStance Health Group Stock Performance
Shares of LFST opened at $6.20 on Friday. The company’s 50 day simple moving average is $6.28 and its 200-day simple moving average is $7.72. The firm has a market cap of $2.35 billion, a PE ratio of -11.92 and a beta of 1.08. LifeStance Health Group has a 12-month low of $4.22 and a 12-month high of $9.59. The company has a current ratio of 1.10, a quick ratio of 1.10 and a debt-to-equity ratio of 0.17.
LifeStance Health Group (NASDAQ:LFST – Get Free Report) last issued its quarterly earnings data on Wednesday, November 8th. The company reported ($0.17) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.07) by ($0.10). LifeStance Health Group had a negative return on equity of 12.59% and a negative net margin of 18.72%. The business had revenue of $262.90 million for the quarter, compared to analysts’ expectations of $255.18 million. During the same period in the previous year, the business posted ($0.11) earnings per share. The company’s revenue for the quarter was up 20.8% on a year-over-year basis. As a group, equities analysts predict that LifeStance Health Group will post -0.44 EPS for the current year.
Insider Buying and Selling at LifeStance Health Group
Institutional Trading of LifeStance Health Group
A number of institutional investors have recently modified their holdings of the business. Stockbridge Partners LLC acquired a new stake in LifeStance Health Group in the first quarter valued at $53,529,000. Brown Advisory Inc. acquired a new stake in shares of LifeStance Health Group in the third quarter valued at about $28,140,000. Vanguard Group Inc. boosted its holdings in LifeStance Health Group by 79.6% during the first quarter. Vanguard Group Inc. now owns 6,202,930 shares of the company’s stock worth $62,711,000 after buying an additional 2,749,277 shares in the last quarter. BlackRock Inc. grew its position in LifeStance Health Group by 36.1% during the second quarter. BlackRock Inc. now owns 7,093,100 shares of the company’s stock worth $64,760,000 after buying an additional 1,879,857 shares during the period. Finally, FMR LLC grew its position in LifeStance Health Group by 6.7% during the third quarter. FMR LLC now owns 28,178,666 shares of the company’s stock worth $193,587,000 after buying an additional 1,758,427 shares during the period. 76.98% of the stock is currently owned by hedge funds and other institutional investors.
About LifeStance Health Group
LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.
- Five stocks we like better than LifeStance Health Group
- How to Start Investing in Penny Stocks
- The most upgraded stocks in November have two things in common
- How to Invest in Fertilizer
- Monday.com rocked earnings like it’s the weekend
- 3 REITs to Buy and Hold for the Long Term
- Plan to own one retailer? Make it this one
Receive News & Ratings for LifeStance Health Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifeStance Health Group and related companies with MarketBeat.com's FREE daily email newsletter.